Quest Diagnostics (DGX) Long-Term Debt Repayments (2009 - 2026)

Quest Diagnostics has disclosed Long-Term Debt Repayments across 18 years of filings, most recently posting $1.0 million for Q1 2026.

• Long-Term Debt Repayments for Q1 2026 came in at $1.0 million, down 99.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $413.0 million (down 54.26% YoY), and the FY2025 annual result was $1.0 billion, up 233.99% from the prior year.
• Long-Term Debt Repayments came in at $1.0 million for Q1 2026 at Quest Diagnostics, roughly flat from $1.0 million in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $688.0 million in Q2 2023 to a low of $1.0 million in Q1 2022.
• The 5-year median for Long-Term Debt Repayments is $75.0 million (2023), against an average of $225.9 million.
• Across the five-year window, Long-Term Debt Repayments surged 41700.0% in 2023 and plunged 99.83% in 2026, its largest moves.
• Quest Diagnostics' Long-Term Debt Repayments stood at $1.0 million in 2022, then soared by 41700.0% to $418.0 million in 2023, then slumped by 99.76% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025, then changed by 0.0% to $1.0 million in 2026.
• The last three Long-Term Debt Repayments figures came in at $1.0 million (Q1 2026), $1.0 million (Q4 2025), and $10.0 million (Q3 2025), per Business Quant data.